Exercise on GLP-1 Medications: Building a Routine That Works

Most exercise advice published before 2022 treats appetite as something to be managed downward through activity. The standard frame: work out, burn calories, deal with the resulting hunger, repeat. Whatever else can be said about that frame, it does not describe what training looks like for someone whose hunger has been pharmacologically quieted and whose stomach is emptying at half the previous rate.

A patient three months into semaglutide titration who tries to apply pre-2022 fitness advice to their current physiology will run into a series of small surprises. The pre-workout meal that used to settle in forty-five minutes now sits heavy at the start of mile two. The afternoon hunger that used to drive a productive gym session simply doesn't arrive. The scale moves down but the bicep doesn't quite fill the same shirt sleeve. None of these are problems exactly, but they all signal that the rules have changed.

The lean tissue arithmetic that reshuffles every priority

The most consequential finding in GLP-1 exercise science arrived through MRI. Olof Linge and colleagues at AMRA Medical, working with sub-study data from STEP 1, used precision body composition imaging to break down where the weight loss on semaglutide was actually coming from. The 2024 paper in Diabetes, Obesity and Metabolism reported that lean tissue accounted for roughly 40% of total weight lost. Fat tissue accounted for the majority — the trial worked as a fat-loss intervention — but the lean tissue fraction was substantial and consistent with what large weight losses through any intervention typically produce.

This ratio is not unique to GLP-1 medications. Caloric restriction of any kind, surgical weight loss, and severe dieting all produce comparable lean tissue losses. What's different is that GLP-1 medications now make 15-to-20% body weight loss reproducibly achievable for large numbers of patients, which means the lean tissue arithmetic — previously most relevant to bariatric surgery candidates — is now a mass-market clinical question.

Forty percent of the total weight loss being lean tissue is not a problem when it tracks roughly with what a body needs at the new size. It becomes a problem when the lean tissue lost is functional muscle, particularly the muscle that contributes to insulin sensitivity, basal metabolic rate, and quality of life as people age. Resistance training and adequate protein intake change the ratio. They are the two interventions that have been shown, across multiple weight-loss contexts, to shift the loss back toward fat and preserve more lean mass.

Why this makes resistance training the centrepiece, not cardio

Pre-GLP-1 fitness culture often framed cardio as the primary tool for weight management, with strength training as a complement. The biology of large weight loss inverts that priority. Cardio contributes to total energy expenditure and cardiovascular fitness, both of which matter. It does little to preserve lean mass during a caloric deficit. Resistance training, performed with adequate intensity and frequency, provides the signal that tells the body to retain skeletal muscle even while losing weight.

Stuart Phillips and colleagues at McMaster University have published extensively on protein and resistance training during weight loss. The picture from their work is consistent: people who lift heavy things two or three times a week, while eating adequate protein, retain substantially more lean mass than people who don't. The interventions stack — neither alone is as effective as both together — but the resistance training piece is the harder one to substitute. There is no protein intake that fully compensates for the absence of a mechanical loading signal.

For most GLP-1 patients, this means the weekly exercise plan should anchor around two-to-three resistance training sessions, with cardio and incidental movement built around them rather than the reverse.

Fueling around slowed gastric emptying

GLP-1 medications can extend gastric emptying time by several hours at higher doses. The practical implication for exercise is that the pre-workout fueling strategies most active adults learned from running and cycling culture stop working as designed. A bowl of oats ninety minutes before a hard session was a reasonable plan in 2020. On a 2.4mg dose of semaglutide, the same oats are still in the stomach when the warm-up ends.

The workable adjustments are mostly about timing and texture.

Liquid carbohydrate sources — small servings of fruit juice, sports drinks, or a protein smoothie — clear the stomach faster than solid food and tend to be tolerated better in the hour before training. For sessions longer than 45 minutes, sipping during the workout works better than trying to top up beforehand. Solid pre-workout meals tend to need a 2-to-3-hour window rather than the 60-to-90 minutes that worked previously. None of this is dramatic; it is mostly a matter of moving the meal earlier and adjusting the form.

Post-workout fueling needs slightly more attention than it used to. Appetite suppression means the hunger cue that normally drives post-session eating may simply not arrive, and patients can finish a session and skip the recovery meal without noticing they've done it. The literature on muscle protein synthesis is fairly clear that protein intake in the few hours after a resistance training session contributes meaningfully to the muscle preservation goal. Setting a scheduled post-workout meal — independent of whether hunger has shown up — is one of the more useful behavioural changes patients make on GLP-1 therapy.

Hydration emphasis goes up

Reduced appetite frequently means reduced fluid intake, because so much daily hydration comes incidentally with eating. GLP-1 patients dehydrate more easily than they did pre-medication, and the symptoms — fatigue, headache, dizziness during exercise — can be mistaken for medication side effects when the issue is just fluid status. A water bottle in eyesight throughout the day, with deliberate sipping rather than wait-until-thirsty behaviour, covers most of this. Adding electrolytes during longer or hotter sessions covers the rest.

A weekly structure that fits a beginner

For a patient three months into a GLP-1 with no recent training history, a reasonable starting structure looks like this:

Two resistance training sessions per week, separated by at least one day. Each session 30-to-45 minutes. Focus on compound movements — squat or leg press, hinge or deadlift variation, push (chest press or push-up), pull (row or pull-down), and a carry or core movement. Three sets per exercise, in the 6-to-12 rep range, taken to within 1-to-2 reps of failure. The numbers don't need to be impressive. The signal — heavy enough, repeated regularly — does the work.

Two-to-three cardio sessions per week, mostly low-to-moderate intensity. Walking, easy cycling, or swimming. 30-to-60 minutes per session. The aerobic adaptation matters for cardiovascular health and overall energy capacity. Intense cardio is fine but not the priority during the active weight-loss phase.

Daily incidental movement. Steps, standing breaks, walks after meals. This is the layer that gets quietly subtracted as weight drops (a phenomenon called NEAT reduction), and deliberate effort to maintain daily movement helps offset that.

Most patients ramp into this structure rather than starting at the full volume. Two short walks per day and one resistance session per week, for the first few weeks, is a reasonable on-ramp. The goal is building a routine that survives a year, not impressing a coach in week three.

The energy capacity question

Some patients on GLP-1 medications report reduced exercise capacity, particularly during the titration phase. The mechanism is debated — possibly related to reduced caloric intake, possibly to direct effects on substrate availability, possibly to mild dehydration — but the pattern is real enough that it shows up in patient reports and in some performance-focused subgroups. The workable approach is to expect lower training output during titration weeks and dose increases, then to recalibrate as the body adapts to the new energy availability.

Reducing intensity, not skipping sessions, tends to work better. The exercise stimulus remains useful even if the workout looks lighter than it would have pre-medication. Patients who try to push through at pre-medication intensities sometimes find that they crash mid-session, miss subsequent days, and lose more training stimulus than they would have by simply dialing the intensity back.

Where this fits in the bigger picture

Exercise on a GLP-1 is doing different work than exercise pre-medication. The medication handles most of the appetite and energy balance heavy lifting. Exercise is now primarily about preserving the lean mass that would otherwise be lost as part of any large weight reduction, plus the cardiovascular, metabolic, and quality-of-life benefits that training has always produced. The framing of exercise as a weight-loss tool — which was always somewhat misleading — becomes actively counterproductive on a GLP-1. The medication is the weight-loss tool. Training does something different and more durable.

For patients building a routine from scratch, the deeper material on strength training on Ozempic and other GLP-1s goes into more detail on programming, while realistic weight-loss goals on a GLP-1 sets reasonable expectations for what the scale will do alongside the training.

Key takeaways

• Linge's 2024 STEP 1 MRI sub-study found ~40% of weight loss on semaglutide came from lean tissue — a ratio that's not unique to GLP-1 medications, but is now a mass-market clinical question because of how reproducible large weight loss has become.
• Resistance training (2-to-3 sessions per week) is the central priority because it preserves lean tissue during caloric deficit; cardio is supportive rather than primary.
• Adequate protein intake (around 1.4-to-1.6 g/kg) is the other half of the muscle preservation equation; neither resistance training nor protein alone is as effective as both together.
• Slowed gastric emptying means pre-workout meals need an earlier window (2-to-3 hours for solid food) or lighter, more liquid options; appetite suppression makes post-workout fueling something to schedule deliberately.
• Hydration matters more than usual because reduced eating means reduced incidental fluid intake.
• Training output may drop during titration weeks — adjust intensity rather than skip sessions, and expect capacity to recalibrate as the body adapts.